Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Wiener Medizinische Wochenschrift (1946)|January 1, 1993
[Interferon-alpha therapy in non-Hodgkin's lymphoma]M A FridrikBlut|December 1, 1988
Low dose cytosine arabinoside in refractory anemia with excess of blasts in transformationM A Fridrik, G Wahl, W HerbingerWiener Medizinische Wochenschrift (1946)|November 15, 1988
[Imipenem/cilastatin as monotherapy in neutropenic patients with fever]M A Fridrik, G Wahl, E Grafinger-Witt, et al.The Netherlands Journal of Medicine|June 28, 2017
Torsade de pointes in a patient with severe hypercalcaemia and multiple myelomaD Fuchs, D Voskova, K J Krenosz, et al.Annals of Hematology|January 1, 1997
First-line treatment of Waldenström's disease with cladribine. Arbeitsgemeinschaft Medikamentöse TumortherapieM A Fridrik, G Jäger, C Baldinger, et al.Hematological Oncology|July 1, 1991
Toxicity and preliminary results with a new eight-drug regimen (CEOP-IMVP-DEXA) in the treatment of aggressive lymphomasM A Fridrik, H Hausmaninger, G Michlmayr, et al.Blut|May 1, 1989
Morphological and immunological changes of hairy cell leukemia during alpha-2-interferon therapyM A Fridrik, G Wahl, W Herbinger, et al.Wiener Klinische Wochenschrift|March 21, 1998
Chemotherapy in patients with acquired immunodeficiency virus syndrome associated with non-Hodgkin's lymphomaM A Fridrik, M Geit, G Wahl, et al.Annals of Hematology|December 24, 1997
Randomized open label phase III trial of CEOP/IMVP-Dexa alternating chemotherapy and filgrastim versus CEOP/IMVP-Dexa alternating chemotherapy for aggressive non-Hodgkin's lymphoma (NHL). A multicenter trial by the Austrian Working Group for Medical Tumor TherapyM A Fridrik, R Greil, H Hausmaninger, et al.Pageof 2